HLAVÁČKOVÁ, Eva, Kateřina PILÁTOVÁ, Lenka FĚDOROVÁ, Peter MÚDRY, Pavel MAZÁNEK, Jaroslav ŠTĚRBA a Lenka ZDRAŽILOVÁ DUBSKÁ. Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine. In Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO). 2019. ISSN 0923-7534. Dostupné z: https://dx.doi.org/10.1093/annonc/mdz448.006. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1612076, author = {Hlaváčková, Eva and Pilátová, Kateřina and Fědorová, Lenka and Múdry, Peter and Mazánek, Pavel and Štěrba, Jaroslav and Zdražilová Dubská, Lenka}, booktitle = {Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO)}, doi = {http://dx.doi.org/10.1093/annonc/mdz448.006}, keywords = {monocyte-derived dendritic cell anticancer vaccine}, language = {eng}, title = {Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine}, url = {https://www.annalsofoncology.org/article/S0923-7534(20)34420-3/abstract}, year = {2019} }
TY - CONF ID - 1612076 AU - Hlaváčková, Eva - Pilátová, Kateřina - Fědorová, Lenka - Múdry, Peter - Mazánek, Pavel - Štěrba, Jaroslav - Zdražilová Dubská, Lenka PY - 2019 TI - Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine KW - monocyte-derived dendritic cell anticancer vaccine UR - https://www.annalsofoncology.org/article/S0923-7534(20)34420-3/abstract L2 - https://www.annalsofoncology.org/article/S0923-7534(20)34420-3/abstract N2 - Refractory and relapsing sarcoma and high-risk neuroblastoma show poor prognoses. Monocyte-derived dendritic cell anticancer vaccine could extend the treatment modalities in these patients. Pharmacotherapy prior to mononuclear cell harvest may influence the quality of manufactured dendritic cell product. ER -
HLAVÁČKOVÁ, Eva, Kateřina PILÁTOVÁ, Lenka FĚDOROVÁ, Peter MÚDRY, Pavel MAZÁNEK, Jaroslav ŠTĚRBA a Lenka ZDRAŽILOVÁ DUBSKÁ. Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine. In \textit{Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO)}. 2019. ISSN~0923-7534. Dostupné z: https://dx.doi.org/10.1093/annonc/mdz448.006.
|